Neoadjuvant multimodal treatment of stage IIIA non-small-cell lung cancer;Neoadjuvante multimodale Therapie im Stadium IIIA des nicht-kleinzelligen Bronchialkarzinoms

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 33, 1997, Pages 993-998

  Thomas, M ^a   Rube C ^b   Semik, M ^c   Junker, K ^d   Von Eiff, M ^e  

^a Medizinische Klinik und Poliklinik A   (Germany)

^b Klin fur Strahlentherapie/R   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e Malteser Krankenhaus St Hildegardis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DIMETHOATE; ETOPOSIDE; VINDESINE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TOXICITY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; PROGNOSIS;

EID: 0030751747     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1047719     Document Type: Article

References (30)

1. Albain, K. S.: Induction therapy followed by definitive local control for stage III non-small-cell lung cancer. A review, with a focus on recent trimodality trials. Chest 102 (1993), 43s-50s.
2. Albain, K. S., V. W. Rusch, J. J. Crowley, T. W. Rice, A. T. Turrisi, J. K. Weick, V. A. Lonchyna, C. A. Presant, R. J. McKenna, D. R. Gandara, H. Fosmire, S. A. Taylor, K. J. Stelzer, K. R. Beasley, R. B. Livingston: Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer. Mature results of Southwest Oncology Group phase II study 8805. J. clin. Oncol. 3 (1995), 1880-1892.
3. Bunn, P. A.: The treatment of non-small cell lung cancer. Current perspectives and controversis, future directions. Semin. Oncol. 21 Suppl. 6 (1994), 49-59.
4. Choi, N. C., R. W. Carey, W. Daly, D. Mathisen, J. Wain, C. Wright, T. Lynch, M. Grossbord, H. Grille: Potential impact on survival of improved tumor downstaging and resection rate by preoperative twicedaily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J. clin. Oncol. 15 (1997), 712-722.
5. Deutsch, M., J. Crawford, K. Leopold, W. Wolfe, W. Foster, J. Herndon, S. Blackwell, R. Yost: Phase II-study of neoadjuvant chemotherapy and radiation-therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer. Cancer (Philad.) 74 (1994), 1243-1252.
6. Eagan, R. T., C. Ruud, R. E. Lee, P. C. Pairolero, M. H. Gail: Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancer. Cancer Treatm. Rep. 71 (1987), 895-900.
7. Eberhardt, W., H. Wilke, G. Stamatis, M. Stuschke, M. R. Müller, D. Greschuchna, N. Konietzko, S. Seeber: Präoperative Chemotherapie und Chemo-/Radiotherapie beim lokal fortgeschrittenen NSCLC. Pneumologie 505 (1996), 142.
8. Edelman, M. J., D. R. Gandara, M. Roach, J. R. Benfield: Multiomodality therapy in stage III non-small cell lung cancer. Ann. Thorac. Surg. 61 (1996), 1564-1572.
9. Faber, L. P., C. F. Kittle, W. H. Warren, P. D. Bonomi, S. G. Taylor, S. Reddy, M. S. Lee: Praeoperative chemotherapy and irradiation for stage III non-small-cell lung cancer. Ann. Thorac. Surg. 47 (1989), 669-675.
10. Fowler, W. C., C. J. Langer, W. J. Curran, S. M. Keller: Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann. Thorac. Surg. 55 (1993), 986-989.
11. st ed. (Lippincott-Raven: New York 1996), 863-873.
12. Junker, K., M. Thomas, K. Schulmann, V. Klinke, U. Bosse, K. M. Müller: Regressionsgrading neoadjuvant behandelter nicht-klein-zelliger Lungenkarzinome. Pathologe 18 (1997), 131-140.
13. Kaplan, E. L., P. Meier: Non-parametric estimation from incomplete observations. J. Amer. Stat. Assoc. 53 (1958), 457-481.
14. Konietzko, N.: Abschätzung des präoperativen Risikos bei vorbestehenden Lungenerkrankungen. Internist 33 (1992), 379-386.
15. Lilenbaum, R. C., M. R. Green: Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer. J. clin. Oncol. 11 (1993), 1391-1402.
16. Manegold, C., J. Schirren, P. Schneider, P. Drings, I. Vogt-Moykopf, P. Schraube, M. Wannenmacher: Gegenwärtiger Stand der interdisziplinären Therapie des Stadium III des nicht-kleinzelligen Bronchialkarzinoms. Pneumologie 505 (1996), 735-741.
17. Martini, N., B. J. Flehinger: The role of surgery in N2 lung cancer. Surg. Clin. N. Amer. 7 (1987), 1037-1049.
18. Mathisen, D. J., J. C. Wain, C. Wright, N. Choi, R. Carey, A. Hilgenberg, M. Grossbard, T. Lynch, H. Grillo: Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIA (N2) non-small-cell lung cancer. J. Thorac. Cardiovasc. Surg. 111 (1996), 123-133.
19. Mountain, C. F.: Prognostic implications of the International Staging System for lung cancer. Semin. Oncol. 15 (1988), 236-245.
20. Pearson, F. G., N. C. De Larue, R. Ilves, T. R. Todd, J. D. Cooper: Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J. Thorac. Cardiovasc. Surg. 83 (1982), 1-11.
21. Recine, D., K. Rowland, S. Reddy, M. S. Lee, P. Bonomi, S. Taylor, L. P. Faber, W. Warren, C. F. Kittle, F. R. Hendrickson: Combined modality therapy for locally advanced non-small cell lung carcinoma. Cancer (Philad.) 66 (1990), 2270-2278.
22. Rusch, V. W.: Neoadjuvant chemotherapy for stage III lung cancer. Semin. Thorac. Cardiovasc. Surg. 5 (1993), 258-267.
23. Shepherd, F. A.: Induction chemotherapy for locally advanced non-small cell lung cancer. Ann. Thorac. Surg. 55 (1993), 1585-1592.
24. Skarin, A., M. Jochelson, T. Sheledon, A. Malcolm, P. Olinyk, R. Overholt, M. Hunt, E. Frei: Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small-cell lung cancer. Long-term follow-up in 41 patients. J. Surg. Oncol. 40 (1989), 266-274.
25. Strauss, G. M., J. E. Herndon, D. D. Sherman, D. J. Mathisen, R. W. Carey, N. C. Shoi, V. B. Rege, C. Modeas, M. R. Green: Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA nonsmall cell carcinoma of the lung. Report of cancer and leukemia group B phase II study. J. clin. Oncol. 10 (1992), 1237-1244.
26. Taylor, S. G., M. Trybula, P. D. Bonomi, L. P. Faber, M. S. Lee, S. Reddy, S. C. Maffey, D. J. Mathisen, R. J. Jensik, C. F. Kittle: Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small-cell lung cancer. Ann. Thorac. Surg. 43 (1987), 87-91.
27. Thomas, M., H.-N. Macha, C. Rübe, J. van de Loo: Stellenwert der Chemotherapie in der Behandlung des nicht-kleinzelligen Bronchialkarzinomes. Dtsch. med. Wschr. 120(1995), 1627-1630.
28. Weiden, P. L., S. Piantadosi: Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer. A phase II study of the lung cancer study group. J. nat. Cancer Inst. 83 (1991), 266-272.
29. Weitberg, A. B., J. Yashar, A. S. Glicksmann, M. Posner, F. Cummings, M. Browne, J. Clark, P. Calabresi, J. Beitz, C. Murray: Combined modality therapy for stage IIIA non-small cell carcinoma of the lung. Europ. J. Cancer 29 (1993), 511-515.
30. Yashar, J., A. B. Weitberg, A. S. Glicksmann, M. R. Posner, W. Feng, H. J. Wanebo: Preoperative chemotherapy and radiation therapy for stage IIIA carcinoma of the lung. Ann. Thorac. Surg. 53 (1992), 445-448.